Meridian Bioscience reported $61.03M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US USD 8.76B 123M
Atrion ATRI:US USD 34.05M 3.8M
Becton, Dickinson and BDX:US USD 4B 293M
Bio Rad Laboratories BIO:US USD 611.62M 23.61M
Cerus CERS:US USD 61.27M 7.48M
Myriad Genetics MYGN:US USD 230M 28.6M
Neogen NEOG:US USD 237.69M 111.4M
Orasure Technologies OSUR:US USD 109.64M 5.94M
Quidel QDEL:US USD 780M 53M
Rockwell Medical RMTI:US USD 22.4M 765K
Sientra SIEN:US USD 35.13M 2.32M
Staar Surgical STAA:US USD 63.08M 739K
Thermo Fisher Scientific TMO:US USD 9.59B 622M
Utah Medical Products UTMD:US USD 7.81M 557K